EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 99 filers reported holding EDITAS MEDICINE INC in Q1 2017. The put-call ratio across all filers is 2.11 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $450,202 | -21.8% | 96,403 | +24.2% | 0.00% | – |
Q1 2024 | $575,922 | -25.6% | 77,618 | +1.6% | 0.00% | – |
Q4 2023 | $773,761 | +16.2% | 76,383 | -10.5% | 0.00% | – |
Q3 2023 | $665,848 | +2.0% | 85,365 | +7.6% | 0.00% | – |
Q2 2023 | $652,780 | -17.2% | 79,317 | -27.1% | 0.00% | – |
Q1 2023 | $788,282 | +64.5% | 108,728 | +101.3% | 0.00% | – |
Q4 2022 | $479,082 | -30.4% | 54,012 | -3.9% | 0.00% | – |
Q3 2022 | $688,000 | +39.6% | 56,186 | +34.8% | 0.00% | – |
Q2 2022 | $493,000 | -45.0% | 41,677 | -11.6% | 0.00% | – |
Q1 2022 | $896,000 | -63.8% | 47,134 | -49.5% | 0.00% | – |
Q4 2021 | $2,477,000 | -80.4% | 93,297 | -69.7% | 0.00% | -100.0% |
Q3 2021 | $12,666,000 | +329.9% | 308,347 | +492.8% | 0.00% | – |
Q2 2021 | $2,946,000 | +228.1% | 52,017 | +143.2% | 0.00% | – |
Q1 2021 | $898,000 | -79.4% | 21,386 | -65.6% | 0.00% | – |
Q4 2020 | $4,358,000 | +257.8% | 62,157 | +43.2% | 0.00% | – |
Q3 2020 | $1,218,000 | -67.5% | 43,412 | -65.8% | 0.00% | – |
Q2 2020 | $3,752,000 | +21.1% | 126,833 | -18.8% | 0.00% | – |
Q1 2020 | $3,097,000 | -35.0% | 156,183 | -2.9% | 0.00% | -100.0% |
Q4 2019 | $4,761,000 | +128.1% | 160,794 | +75.2% | 0.00% | – |
Q3 2019 | $2,087,000 | -88.6% | 91,797 | -87.6% | 0.00% | -100.0% |
Q2 2019 | $18,288,000 | -4.1% | 739,203 | -5.2% | 0.00% | 0.0% |
Q1 2019 | $19,064,000 | -35.0% | 779,706 | -39.5% | 0.00% | -50.0% |
Q4 2018 | $29,308,000 | -39.5% | 1,288,287 | -15.4% | 0.00% | -20.0% |
Q3 2018 | $48,471,000 | -53.3% | 1,523,278 | -47.4% | 0.01% | -58.3% |
Q2 2018 | $103,698,000 | -22.6% | 2,894,184 | -28.4% | 0.01% | -25.0% |
Q1 2018 | $134,015,000 | -5.7% | 4,042,657 | -12.5% | 0.02% | -5.9% |
Q4 2017 | $142,056,000 | +30.5% | 4,622,720 | +2.0% | 0.02% | +30.8% |
Q3 2017 | $108,863,000 | +36.1% | 4,534,116 | -4.9% | 0.01% | +30.0% |
Q2 2017 | $79,968,000 | -39.3% | 4,765,641 | -19.2% | 0.01% | -41.2% |
Q1 2017 | $131,721,000 | +47.6% | 5,901,489 | +7.3% | 0.02% | +41.7% |
Q4 2016 | $89,239,000 | +20.5% | 5,498,390 | +0.1% | 0.01% | +20.0% |
Q3 2016 | $74,035,000 | -44.3% | 5,492,112 | +0.7% | 0.01% | -44.4% |
Q2 2016 | $133,030,000 | -28.7% | 5,452,061 | +0.9% | 0.02% | -30.8% |
Q1 2016 | $186,586,000 | – | 5,402,030 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
Knott David M Jr | 177,000 | $827 | 0.33% |
Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |